Vascular Biogenics Ltd (VBLT)

[mantoo123]

I don't think most investors look at the actual number of months of OS to decide whether to invest or not. Moreover, no one is going to jail for having published OS values in units of weeks instead of months or vice versa.

Regarding VB-111, there is an ongoing phase 3 trial for rGBM under an SPA with the FDA. The p3 tiral is what makes investors take the plunge.

Regarding CEO credibility:

Prof. Harats has an illustrious career as a medical doctor, a researcher at Tel Hashomer, Israel's largest hospital, and as a faculty member at Tel-Aviv university.

He is also surrounded by high calibre people with years of experience in clinical trials and related fields.

I understand that the ability to prosecute and jail a CEO might be reassuring to some investors. However, we can assume that there exist guarantees put in place by the SEC so that US investors are not easily scammed. Admittedly, I do not know the actual guarantees involved.

Notwithstanding the above, it is entirely possible that VB-111 is a dud as many have claimed in the past. We will find out shortly.